Cathay Health
VC Fund
Paris, France
Cathay Health is a global fund investing at the convergence of healthcare, life sciences and technology.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Cathay Health invests in
Stages Cathay Health invests in
Countries Cathay Health invests in
Investment Focus
Industry
- Biotechnology 2 (67%)
- Big Data 1 (33%)
- Consulting 1 (33%)
- Health Care 1 (33%)
- Therapeutics 1 (33%)
Stage
- Series A 1 (33%)
- Series C 1 (33%)
- Series D 1 (33%)
Country
- China 1 (33%)
- France 1 (33%)
- United Kingdom 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
TISSIUM
|
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid development and the commercialization of revolutionary biodegradable sealants and adhesives for wound closure in the field of surgery, with a key focus on minimally invasive surgery. TISSIUM is developing products that are non-toxic, bindstrongly to tissues, and deliver on-demand wound closure within the ‘wet’ and dynamic environments in the body. The Company’s technology and products are based on world-class research and intellectual property from the laboratories of Robert Langer (MIT) and Jeff Karp (Brigham & Women’s Hospital). Gecko was founded in 2013 and is backed by leading healthcare investors Omnes Capital, CM-CIC, and CapDecisif Management. | $53.8M / Series D / May 23, 2023 | |
Ascend Gene & Cell Therapies
|
Ascend Gene & Cell Therapies supports manufacturing and process development projects from design through to clinical and commercial scales. They partner with biotechnology teams to embed scalable manufacturing in their operations from the beginning. They respond to customer inquiries by phone and contact form. | $65.9M / Series A / Mar 20, 2023 | |
DataStory
|
DataStory is a big data and AI intelligent business application provider. | $23.4M / Series C / Jun 16, 2021 |
Co-Investors
4BIO Capital
2 deals together
Abingworth
2 deals together
DCVC Bio
2 deals together
Ajinomoto
1 deal together
Crédit Mutuel Innovation
1 deal together
Deerfield Capital Management
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Cathay Health invest in?
Cathay Health invests primarily in Biotechnology, Big Data and Consulting startups, most often at Series A and Series C stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Cathay Health last invest?
The most recent investment recorded for Cathay Health closed in May 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
